{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:57:57Z","timestamp":1771657077303,"version":"3.50.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["NIDDK R01DK123233"],"award-info":[{"award-number":["NIDDK R01DK123233"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s10620-023-07983-5","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T03:27:49Z","timestamp":1688527669000},"page":"3562-3568","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sweet Syndrome Associated with Active Inflammatory Bowel Disease: A Case Series of a Rare Extra-intestinal Manifestation"],"prefix":"10.1007","volume":"68","author":[{"given":"Joseph","family":"Sleiman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihir","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Zarrar","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Falloon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Click","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urmi","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony P.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9087-1568","authenticated-orcid":false,"given":"Florian","family":"Rieder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"7983_CR1","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1097\/mib.0000000000000429","volume":"21","author":"SR Vavricka","year":"2015","unstructured":"Vavricka SR, Rogler G, Gantenbein C et al. Chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis in the swiss inflammatory bowel disease cohort. Inflamm Bowel Dis. 2015;21:1794\u20131800. https:\/\/doi.org\/10.1097\/mib.0000000000000429.","journal-title":"Inflamm Bowel Dis."},{"key":"7983_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/00005792-197609000-00004","volume":"55","author":"AJ Greenstein","year":"1976","unstructured":"Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn\u2019s disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore). 1976;55:401\u2013412. https:\/\/doi.org\/10.1097\/00005792-197609000-00004.","journal-title":"Medicine (Baltimore)."},{"key":"7983_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1750-1172-2-34","volume":"2","author":"PR Cohen","year":"2007","unstructured":"Cohen PR. Sweet\u2019s syndrome\u2013a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis. 2007;2:34. https:\/\/doi.org\/10.1186\/1750-1172-2-34.","journal-title":"Orphanet J Rare Dis."},{"key":"7983_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjab079","author":"J Sleiman","year":"2021","unstructured":"Sleiman J, Hitawala AA, Cohen B et al. Systematic review: Sweet syndrome associated with inflammatory bowel disease. J Crohns Colitis. 2021. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab079.","journal-title":"J Crohns Colitis"},{"key":"7983_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16853","author":"K Falloon","year":"2022","unstructured":"Falloon K, Cohen B, Ananthakrishnan AN et al. A United States expert consensus to standardise definitions, follow-up, and treatment targets for extra-intestinal manifestations in inflammatory bowel disease. Aliment Pharmacol Ther. 2022. https:\/\/doi.org\/10.1111\/apt.16853.","journal-title":"Aliment Pharmacol Ther."},{"key":"7983_CR6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S2468-1253(21)00297-1","volume":"7","author":"L Guillo","year":"2022","unstructured":"Guillo L, Abreu M, Panaccione R et al. Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases. Lancet Gastroenterol Hepatol. 2022;7:254\u2013261. https:\/\/doi.org\/10.1016\/S2468-1253(21)00297-1.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"7983_CR7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jaad.2013.06.023","volume":"69","author":"NM Rochet","year":"2013","unstructured":"Rochet NM, Chavan RN, Cappel MA, Wada DA, Gibson LE. Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients. J Am Acad Dermatol. 2013;69:557\u2013564. https:\/\/doi.org\/10.1016\/j.jaad.2013.06.023.","journal-title":"J Am Acad Dermatol."},{"key":"7983_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw199","author":"MC Karreman","year":"2016","unstructured":"Karreman MC, Luime JJ, Hazes JMW, Weel AEAM. The prevalence and incidence of axial and peripheral spondyloarthritis in inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis. 2016. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw199.","journal-title":"J Crohns Colitis"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-07983-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-023-07983-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-07983-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T02:08:34Z","timestamp":1692756514000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-023-07983-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["7983"],"URL":"https:\/\/doi.org\/10.1007\/s10620-023-07983-5","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,5]]},"assertion":[{"value":"27 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"F.R. is consultant to Agomab. Allergan, AbbVie, Boehringer Ingelheim, Celgene, Cowen, Falk Pharma, Genentech, Gilead, Gossamer, Guidepoint, Helmsley, Index Pharma, Jannsen, Koutif, Mestag, Metacrine, Morphic, Origo, Pfizer, Pliant, Prometheus, Receptos, RedX, Roche, Samsung, Takeda, Techlab, Theravance, Thetis, UCB and received funding from the National Institute of Health, Helmsley Charitable Trust, Crohn\u2019s and Colitis Foundation, Rainin Foundation, UCB, Boehringer-Ingelheim, Pliant, Morphic, BMS, 89Bio. B.H.C. is a consultant to Takeda, TARGET-RWE and serves on speakers bureau for Takeda. B.L.C. receives the following financial support: Advisory Boards and Consultant for Abbvie, Celgene-Bristol Myers Squibb, Lilly, Pfizer, Sublimity Therapeutics, Takeda, TARGET RWE; CME Companies: Cornerstones, Vindico; Speaking: Abbvie. J.S. receives funding from Pfizer. K.F. receives funding from the Crohn\u2019s and Colitis Foundation. A.P.F. is a consultant to AbbVie, Novartis, Mallinckrodt and Alexion, serves on speaker bureau for AbbVie, Novartis and Mallinckrodt, and receives research funding from Corbus, Pfizer, AbbVie, Novartis, and Mallinckrodt. M.P., M.Z.K. and U.K. have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}